Recombinant Human m7GpppN-mRNA hydrolase (DCP2)

In Stock
Code CSB-EP810265HU
MSDS
Size $224
Order now
Image
  • (Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.

Have Questions? Leave a Message or Start an on-line Chat

Product Details

Purity
Greater than 90% as determined by SDS-PAGE.
Target Names
DCP2
Uniprot No.
Research Area
Transcription
Alternative Names
DCP2; DCP2 decapping enzyme homolog (S. cerevisiae); DCP2, S. cerevisiae, homolog of; DCP2_HUMAN; decapping enzyme 2, S. cerevisiae, homolog of; decapping enzyme homolog (S. cerevisiae); FLJ33245; hDpc; m7GpppN-mRNA hydrolase; mRNA decapping enzyme 2; mRNA-decapping enzyme 2; Nucleoside diphosphate-linked moiety X motif 20; nudix (nucleoside diphosphate linked moiety X)-type motif 20; Nudix motif 20; NUDT20
Species
Homo sapiens (Human)
Source
E.coli
Expression Region
1-385aa
Target Protein Sequence
METKRVEIPGSVLDDLCSRFILHIPSEERDNAIRVCFQIELAHWFYLDFYMQNTPGLPQCGIRDFAKAVFSHCPFLLPQGEDVEKVLDEWKEYKMGVPTYGAIILDETLENVLLVQGYLAKSGWGFPKGKVNKEEAPHDCAAREVFEETGFDIKDYICKDDYIELRINDQLARLYIIPGIPKDTKFNPKTRREIRNIEWFSIEKLPCHRNDMTPKSKLGLAPNKFFMAIPFIRPLRDWLSRRFGDSSDSDNGFSSTGSTPAKPTVEKLSRTKFRHSQQLFPDGSPGDQWVKHRQPLQQKPYNNHSEMSDLLKGKKCEKKLHPRKLQDNFETDAVYDLPSSSEDQLLEHAEGQPVACNGHCKFPFSSRAFLSFKFDHNAIMKILDL
Note: The complete sequence including tag sequence, target protein sequence and linker sequence could be provided upon request.
Mol. Weight
48.4kDa
Protein Length
Full Length of Isoform 2
Tag Info
N-terminal 6xHis-tagged
Form
Liquid or Lyophilized powder
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
Buffer
If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol.
Note: If you have any special requirement for the glycerol content, please remark when you place the order.
If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
Reconstitution
We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final concentration of glycerol is 50%. Customers could use it as reference.
Troubleshooting and FAQs
Storage Condition
Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Shelf Life
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Lead Time
3-7 business days
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Datasheet & COA
Please contact us to get it.
Description

m7GpppN-mRNA hydrolase (DCP2) is a crucial enzyme involved in mRNA decay processes. DCP2, a conserved NUDIX hydrolase, functions as a decapping enzyme by cleaving the 5’ m7G cap of mRNA, leading to the release of m7GDP and a 5’-end monophosphorylated RNA [1][2][3]. It has been shown to be an essential component of the decapping complex and is involved in the hydrolysis of cap structures generated by mRNA decay [4][2]. DCP2 is an RNA-binding protein that selectively binds to specific mRNAs containing a stem-loop structure near the 5' cap, indicating its role in selective mRNA decay [5]. Additionally, DCP2 has been implicated in various mRNA decay processes, suggesting its differential utilization in different pathways [6]. The enzyme's activity can be influenced by both sequence and context, indicating its potential contribution to gene regulation in multiple RNA pathways [7].

Furthermore, DCP2 is a central player in mRNA metabolism, and its molecular basis of mRNA decapping has been intensively studied [8]. It is conserved among eukaryotes and is considered the major decapping enzyme in yeast, indicating its significance in the 5′ to 3′ mRNA decay pathway [9][10]. DCP2 has also been shown to interact with other proteins, such as tristetraprolin (TTP), to mediate mRNA decay, highlighting its role in facilitating the assembly of decay-competent mRNPs [11]. Moreover, DCP2's function is not limited to yeast, as it has been implicated in mRNA decay processes in mammalian cells, raising questions about its exclusivity as the major decapping enzyme in multicellular organisms [12].

References:
[1] J. Lobel, R. Tibble, & J. Gross, "Pat1 activates late steps in mrna decay by multiple mechanisms",, 2019. https://doi.org/10.1101/594168
[2] S. Kramer, "The apah-like phosphatase tbalph1 is the major mrna decapping enzyme of trypanosomes", Plos Pathogens, vol. 13, no. 6, p. e1006456, 2017. https://doi.org/10.1371/journal.ppat.1006456
[3] C. Chang, N. Bercovich, B. Loh, S. Jonas, & E. Izaurralde, "The activation of the decapping enzyme dcp2 by dcp1 occurs on the edc4 scaffold and involves a conserved loop in dcp1", Nucleic Acids Research, vol. 42, no. 8, p. 5217-5233, 2014. https://doi.org/10.1093/nar/gku129
[4] V. Taverniti and B. Séraphin, "Elimination of cap structures generated by mrna decay involves the new scavenger mrna decapping enzyme aph1/fhit together with dcps", Nucleic Acids Research, vol. 43, no. 1, p. 482-492, 2014. https://doi.org/10.1093/nar/gku1251
[5] E. Grudzien-Nogalska and M. Kiledjian, "New insights into decapping enzymes and selective mrna decay", Wiley Interdisciplinary Reviews - Rna, vol. 8, no. 1, 2016. https://doi.org/10.1002/wrna.1379
[6] Y. Li, M. Song, & M. Kiledjian, "Differential utilization of decapping enzymes in mammalian mrna decay pathways", Rna, vol. 17, no. 3, p. 419-428, 2011. https://doi.org/10.1261/rna.2439811
[7] L. Cohen, C. Mikhli, X. Jiao, M. Kiledjian, G. Kunkel, & R. Davis, "Dcp2 decaps m2,2,7gpppn-capped rnas, and its activity is sequence and context dependent", Molecular and Cellular Biology, vol. 25, no. 20, p. 8779-8791, 2005. https://doi.org/10.1128/mcb.25.20.8779-8791.2005
[8] M. Deshmukh, B. Jones, D. Quang-Dang, J. Flinders, S. Floor, C. Kimet al., "Mrna decapping is promoted by an rna-binding channel in dcp2", Molecular Cell, vol. 29, no. 3, p. 324-336, 2008. https://doi.org/10.1016/j.molcel.2007.11.027
[9] M. Kim and A. Hoof, "Suppressors of mrna decapping defects isolated by experimental evolution ameliorate transcriptome disruption without restoring mrna decay",, 2020. https://doi.org/10.1101/2020.06.14.151068
[10] S. Erickson, E. Corpuz, J. Maloy, C. Fillman, W. K, E. Bennettet al., "Competition between decapping complex formation and ubiquitin-mediated proteasomal degradation controls human dcp2 decapping activity", Molecular and Cellular Biology, vol. 35, no. 12, p. 2144-2153, 2015. https://doi.org/10.1128/mcb.01517-14
[11] V. Maciej, N. Mateva, J. Schwarz, T. Dittmers, M. Mallick, H. Urlaubet al., "Intrinsically disordered regions of tristetraprolin and dcp2 directly interact to mediate decay of are-mrna", Nucleic Acids Research, vol. 50, no. 18, p. 10665-10679, 2022. https://doi.org/10.1093/nar/gkac797
[12] M. Song, L. You, & M. Kiledjian, "Multiple mrna decapping enzymes in mammalian cells", Molecular Cell, vol. 40, no. 3, p. 423-432, 2010. https://doi.org/10.1016/j.molcel.2010.10.010

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Decapping metalloenzyme that catalyzes the cleavage of the cap structure on mRNAs. Removes the 7-methyl guanine cap structure from mRNA molecules, yielding a 5'-phosphorylated mRNA fragment and 7m-GDP. Necessary for the degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Plays a role in replication-dependent histone mRNA degradation. Has higher activity towards mRNAs that lack a poly(A) tail. Has no activity towards a cap structure lacking an RNA moiety. The presence of a N(6)-methyladenosine methylation at the second transcribed position of mRNAs (N(6),2'-O-dimethyladenosine cap; m6A(m)) provides resistance to DCP2-mediated decapping. Blocks autophagy in nutrient-rich conditions by repressing the expression of ATG-related genes through degradation of their transcripts.
Gene References into Functions
  1. Human Dcp2 levels and activity are controlled by a competition between decapping complex assembly and Dcp2 degradation. PMID: 25870104
  2. Data show that Y14 interacts directly with the decapping factor Dcp2 and the 5' cap structure of mRNAs via different but overlapping domains. PMID: 23115303
  3. an mRNA decapping enzyme demonstrated to contain intrinsic decapping activity PMID: 12218187
  4. Human Dcp2 is a catalytically active mRNA decapping enzyme that localizes to the cytoplasm PMID: 12486012
  5. hDcp2 can specifically bind to and can regulate the stability of a subset of mRNAs PMID: 18039849
  6. These data support the novel notion of the association between Ro52 with hDCP2 protein in cytoplasmic p-bodies, playing a role in mRNA metabolism in response to cellular stimulation. PMID: 18361920

Show More

Hide All

Subcellular Location
Cytoplasm, P-body. Nucleus.
Protein Families
Nudix hydrolase family, DCP2 subfamily
Tissue Specificity
Expressed in brain and testis. Not detected in heart (at protein level).
Database Links

HGNC: 24452

OMIM: 609844

KEGG: hsa:167227

STRING: 9606.ENSP00000373715

UniGene: Hs.443875

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*